Free Trial

Aethlon Medical Q3 2023 Earnings Report

Aethlon Medical logo
$0.66 -0.05 (-7.10%)
As of 01/17/2025 04:00 PM Eastern

Aethlon Medical EPS Results

Actual EPS
-$1.20
Consensus EPS
-$0.40
Beat/Miss
Missed by -$0.80
One Year Ago EPS
N/A

Aethlon Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aethlon Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Aethlon Medical Earnings Headlines

Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!
Maxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)
See More Aethlon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aethlon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aethlon Medical and other key companies, straight to your email.

About Aethlon Medical

Aethlon Medical (NASDAQ:AEMD), a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

View Aethlon Medical Profile

More Earnings Resources from MarketBeat